⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for standard lymphodepletion regimen

Every month we try and update this database with for standard lymphodepletion regimen cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple SclerosisNCT06384976
Multiple Sclero...
Multiple Sclero...
Multiple Sclero...
KYV-101
Standard lympho...
Anti-CD20 mAB
18 Years - 60 YearsKyverna Therapeutics
A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Subjects With Refractory Generalized Myasthenia GravisNCT06193889
Myasthenia Grav...
Generalized Mya...
KYV-101
Standard lympho...
18 Years - 75 YearsKyverna Therapeutics
A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Subjects With Refractory Generalized Myasthenia GravisNCT06193889
Myasthenia Grav...
Generalized Mya...
KYV-101
Standard lympho...
18 Years - 75 YearsKyverna Therapeutics
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: